Experience Fenwick Represents CoreWeave in Upsized $2 Billion Offering of Senior Notes Due 2030 May 21, 2025
Experience Fenwick Represents Maze Therapeutics in $140M Upsized Initial Public Offering January 30, 2025
Experience Fenwick Represents BILL in $1.4B Offering of 0% Convertible Senior Notes Due 2030 December 6, 2024
Experience Fenwick Represents Underwriters led by Goldman Sachs in Informatica’s $408M Secondary Offering November 12, 2024
Experience Fenwick Represents AnaptysBio in $100M Underwritten Registered Direct Offering August 13, 2024
Experience Fenwick Represents BioAge Labs in $238M Upsized Initial Public Offering and Concurrent Private Placement September 30, 2024
Experience Fenwick Represents Day One Biopharmaceuticals in Oversubscribed $175M Private Placement July 29, 2024